Bioventix PLC
BVXP.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -3.6% | 6.2% | 9.4% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 90.9% | 93.2% | 92.5% | 92.7% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | -£0 | -£0 | -£0 |
| Other Operating Expenses | -£0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Income | £0 | £0 | £0 | £0 |
| % Margin | 75.5% | 77.9% | 78.4% | 79.1% |
| Other Income/Exp. Net | £0 | £0 | £0 | £0 |
| Pre-Tax Income | £0 | £0 | £0 | £0 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | £0 | £0 | £0 | £0 |
| % Margin | 57.8% | 59.5% | 65.3% | 65.5% |
| EPS | 1.45 | 1.55 | 1.61 | 1.47 |
| % Growth | -6.5% | -3.7% | 9.5% | – |
| EPS Diluted | 1.43 | 1.53 | 1.58 | 1.46 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | £0 | £0 | £0 | £0 |
| % Margin | 77.5% | 78.9% | 79.6% | 80.4% |